- Liau, Linda;
- Weiss, William;
- Zhukova, N;
- Ramaswamy, V;
- Remke, M;
- Martin, DC;
- Castelo-Branco, P;
- Zhang, CH;
- Fraser, M;
- Tse, K;
- Poon, R;
- Shih, DJH
TP53 mutations confer subgroup specific poor survival for children with medulloblastoma. We hypothesized that WNT activation which is associated with improved survival for such children abrogates TP53 related radioresistance and can be used to sensitize TP
